Brief: Satsuma Pharmaceuticals Reports Third Quarter 2021 Financial Results And Provides Corporate Update
09/11/2021 22:03
Nov 9 (Reuters) - Satsuma Pharmaceuticals Inc STSA.O :
* SATSUMA PHARMACEUTICALS REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* SATSUMA PHARMACEUTICALS INC - $110 MILLION IN CASH AS OF
SEPTEMBER 30, 2021 PROVIDES RUNWAY INTO SECOND HALF OF 2023
* SATSUMA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.42
Source text for Eikon: ID:nGNX5Hbs6Z
Further company coverage: STSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Satsuma Pharmaceuticals
See all newsBrief: Satsuma Pharmaceuticals Announces FDA Acceptance Of 505(B)(2) NDA For Sts101, A Novel And Investigational Dihydroergotamine Nasal Powder Product For The Acute Treatment Of Migraine
Commencement Of Tender Offer For Satsuma Pharmaceuticals, Inc In U.S.
Brief: Satsuma Pharmaceuticals Says Received Letter Notifying Co Regained Compliance With Nasdaq
U.S. STOCKS ON THE MOVE-Alphabet Inc, BlackRock, Moderna
Satsuma Pharma soars on buyout deal from Japan's Shin Nippon